CD8A and neoplasm: Since Mito-BEZ demonstrated significantly enhanced tumor-infiltrating T cells, especially activated CD8+ T cells through elevated mitochondria function, we speculated that mito-BEZ would facilitate better responses to immune checkpoint blockades, therefore, we tested this theory in two well-known immune checkpoint inhibitor (ICI)-resistant syngeneic mouse tumor models.